CLINICAL TRIALS
Active clinical trials and verified researcher listings for Asthma, simplified into plain English.
ABOUT ASTHMA
Asthma is a common long-term inflammatory disease of the airways. It is characterized by variable and recurring symptoms and reduced lung function. Symptoms include episodes of wheezing, coughing, chest tightness, and shortness of breath. A sudden worsening of asthma symptoms sometimes called an 'asthma attack' or an 'asthma exacerbation' can occur when allergens, pollen, dust, or other particles, are inhaled into the lungs, causing the bronchioles to constrict and produce mucus, which then restricts oxygen flow to the alveoli. These may occur a few times a day or a few times per week. Depending on the person, asthma symptoms may become worse at night or with exercise.
Source: Wikipedia. For educational use only — not medical advice.
ACTIVELY RECRUITING TRIALS
COMMON QUESTIONS
Are there clinical trials currently recruiting for Asthma?
Yes. This page displays actively recruiting Asthma clinical trials sourced in real time from ClinicalTrials.gov. Use the filters to narrow by phase, status, and location.
How do I join a clinical trial for Asthma?
Browse the trials listed above, review the eligibility criteria for each study, and submit a contact request directly to the research team. You can also speak to your physician about a referral.
Are Asthma clinical trials free to participate in?
Most clinical trials cover the cost of the investigational treatment and all study-related visits. Some studies also offer compensation for time and travel. Always confirm costs and insurance coverage with the trial coordinator before enrolling.
What eligibility requirements apply to Asthma trials?
Requirements vary by study. Common criteria include a confirmed Asthma diagnosis, age range, prior treatments, and general health status. Each trial listing shows its specific inclusion and exclusion criteria.
What phases of Asthma trials are available?
Asthma trials span Phase I (safety testing), Phase II (effectiveness), Phase III (comparison to standard care), and Phase IV (post-approval monitoring). Phase II and III trials are most commonly open to new participants.
RELATED CONDITIONS